👀 Take a chance to have a look the email from the ESTP Committee for Regulatory and Scientific Standards (CRSS) on the FDA DRAFT guideline entitled "Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutics" with recommendations for nonclinical development of antisense oligonucleotides, small interfering RNA, microRNA, transfer RNA, decoys and aptamers. Click below 👇 for more information or check your ESTP emails 📧
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/nonclinical-safety-assessment-oligonucleotide-based-therapeutics